Submitted by Anonymous (not verified) on 3 June 2026 - 15:45
Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 23, Status: Authorised
Source: